Connective Tissue Oncology Society

SARC Biannual Meeting
November 19, 2005


8:30 am–8:45 am	Opening Remarks SARC-Who We Are-Laurence H. Baker, DO Background Funding Sources (Pharma/Philanthropy/DOD/RO1) Friend of SARC SARC Salute to Allan VanOosterom
8:45 am–9:45 am	Rosenfeld Developmental Therapeutics Lectureship (15 minute presentation/5 minute Q&A) George Demetri, MD Coordinator Anthony Tolcher, MD Peter Houghton, PhD Richard Gorlick, MD Gaurav Khanna, MD
9:45 am–10:45 am	SARC Update (10 minutes) Open Trials Gleevec Larry Baker, DO Gemcitabine versus Gemcitabine/Docetaxel STS Robert Maki, MD, PhD Gemcitabine/Docetaxel Bone Shreyaskumar Patel, MD Beth Fox, MD Gleevec DFSP Scott Schuetze, MD Gemcitabine/Docetaxel Martee Hensley, MD MPNST/DOD Grant Brigitte Widemann, MD
10:45 am–11:00am	Break
11:00am–12:00 pm	SARC Update (continued) New Concepts/Trials in Development Dasatinib Sarcoma Scott Schuetze, MD, PhD AMG 706 Sarcoma Robert Benjamin, MD Dasatinib/GIST Jon Trent, MD AMG 706/EORTC Robert Maki, MD, PhD Perfosine/Chondrosarcoma and ASPS Dejka Steinert, MD
12:00–12:30 pm	Business Meeting Finances Development/Board of Directors Employee Office Website Guideline Translation